Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN14646628Phase 4Completed
Phase 4, randomised, double-blind trial of chlorhexidine in alveolar osteitis (AO), sponsored by Universidad Austral de Chile. Primary endpoint: Primary outcome: alveolar osteitis diagnosis at 7 days. Started Apr 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN14646628.